Association with tumor grade and GB recurrence (64).In EGFRvIII-expressing glioma cells, association with increased H3K23ac and recruitment of STAT3 to promote GSC proliferation and oncosphere formation (Figure 1D). Rescue by treatment with EGFR inhibitor erlotinib (65). Here, EGFR is linked to central nervous system cancer.